Bernardo Stefanini

750 total citations
32 papers, 172 citations indexed

About

Bernardo Stefanini is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Bernardo Stefanini has authored 32 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 12 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Bernardo Stefanini's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (12 papers) and Cancer Mechanisms and Therapy (5 papers). Bernardo Stefanini is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (12 papers) and Cancer Mechanisms and Therapy (5 papers). Bernardo Stefanini collaborates with scholars based in Italy, United Kingdom and Japan. Bernardo Stefanini's co-authors include Francesco Tovoli, Luca Ielasi, Alessandro Granito, Rusi Chen, Fabio Piscaglia, Ingrid Garajová, Stefania De Lorenzo, Luigi Bolondi, Laura Leoni and Maria Letizia Petroni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Bernardo Stefanini

25 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernardo Stefanini Italy 7 85 47 44 41 36 32 172
Yehia I. Mohamed United States 9 79 0.9× 51 1.1× 47 1.1× 10 0.2× 41 1.1× 20 171
Yasutoshi Fujii Japan 7 40 0.5× 57 1.2× 46 1.0× 57 1.4× 17 0.5× 28 201
Voytek Slowik United States 7 34 0.4× 41 0.9× 24 0.5× 42 1.0× 26 0.7× 15 142
Haifu Wu China 8 52 0.6× 32 0.7× 91 2.1× 94 2.3× 26 0.7× 15 204
M.L. González-Diéguez Spain 9 151 1.8× 134 2.9× 33 0.8× 37 0.9× 29 0.8× 18 234
Jiong-Jie Yu China 6 102 1.2× 57 1.2× 39 0.9× 54 1.3× 11 0.3× 13 160
J. Zou United States 4 196 2.3× 70 1.5× 38 0.9× 52 1.3× 38 1.1× 7 243
Peter R. Galle Germany 5 63 0.7× 44 0.9× 24 0.5× 13 0.3× 25 0.7× 18 114
Marta Piqué‐Gili United Kingdom 4 75 0.9× 19 0.4× 54 1.2× 21 0.5× 17 0.5× 4 125
Mario Domenico Rizzato Italy 8 40 0.5× 13 0.3× 48 1.1× 46 1.1× 21 0.6× 24 120

Countries citing papers authored by Bernardo Stefanini

Since Specialization
Citations

This map shows the geographic impact of Bernardo Stefanini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernardo Stefanini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernardo Stefanini more than expected).

Fields of papers citing papers by Bernardo Stefanini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernardo Stefanini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernardo Stefanini. The network helps show where Bernardo Stefanini may publish in the future.

Co-authorship network of co-authors of Bernardo Stefanini

This figure shows the co-authorship network connecting the top 25 collaborators of Bernardo Stefanini. A scholar is included among the top collaborators of Bernardo Stefanini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernardo Stefanini. Bernardo Stefanini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalbeni, Andrea, Filippo Cattazzo, Bernardo Stefanini, et al.. (2025). What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology. 19(4). 389–398.
2.
Chen, Runsheng, et al.. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?. Digestive and Liver Disease. 57. S56–S56. 1 indexed citations
3.
Celsa, Ciro, Pasquale Lombardi, Antonio D’Alessio, et al.. (2025). Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma. JAMA Oncology. 11(10). 1160–1160.
4.
Stella, Leonardo, Lucia Cerrito, Francesco Santopaolo, et al.. (2025). Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study. Clinical Gastroenterology and Hepatology. 23(13). 2529–2539.e5. 2 indexed citations
5.
Monti, Federico, Laura Leoni, Bernardo Stefanini, et al.. (2024). RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives. International Journal of Molecular Sciences. 25(17). 9193–9193. 6 indexed citations
6.
Ielasi, Luca, Bernardo Stefanini, Fabio Conti, et al.. (2024). Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current Oncology. 31(1). 547–557. 2 indexed citations
7.
Tovoli, Francesco, Bernardo Stefanini, Daniele Mandrioli, et al.. (2024). Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: a prospective pilot study. Digestive and Liver Disease. 56. S53–S53. 1 indexed citations
8.
D’Alessio, Antonio, Bernardo Stefanini, Claudia Angela Maria Fulgenzi, et al.. (2024). Qualification of major pathological response as a surrogate endpoint for relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.. Journal of Clinical Oncology. 42(3_suppl). 506–506. 2 indexed citations
9.
10.
Stefanini, Bernardo, et al.. (2024). Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?. SHILAP Revista de lepidopterología. 24(1). 23–32. 3 indexed citations
11.
Tovoli, Francesco, Bernardo Stefanini, Daniele Mandrioli, et al.. (2023). Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study. Digestive and Liver Disease. 56(4). 571–578. 8 indexed citations
12.
Ielasi, Luca, Francesco Tovoli, Bernardo Stefanini, et al.. (2023). Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cancers. 15(5). 1523–1523. 4 indexed citations
13.
Stefanini, Bernardo, et al.. (2023). TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy. 23(3). 279–291. 74 indexed citations
14.
Leoni, Laura, Bernardo Stefanini, Elton Dajti, et al.. (2023). Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. International Journal of Molecular Sciences. 24(8). 7517–7517. 11 indexed citations
15.
Ielasi, Luca, Bernardo Stefanini, Fabio Piscaglia, Alessandro Granito, & Francesco Tovoli. (2023). A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival. Gastroenterology Insights. 14(1). 38–44. 1 indexed citations
16.
Renzulli, Matteo, Nicolò Brandi, Stefano Brocchi, et al.. (2023). Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!. Journal of Anatomy. 242(4). 683–694. 8 indexed citations
17.
Benevento, Francesca, Anna Pecorelli, Horia Ştefănescu, et al.. (2023). Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients. Journal of Hepatocellular Carcinoma. Volume 10. 473–482. 3 indexed citations
18.
Ferri, S., Bernardo Stefanini, Lorenzo Mulazzani, et al.. (2022). Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients. 14(12). 2493–2493. 7 indexed citations
19.
Renzulli, Matteo, Anna Pecorelli, Nicolò Brandi, et al.. (2022). Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Gastroenterology Insights. 13(3). 275–285. 4 indexed citations
20.
Lorenzo, Stefania De, Ingrid Garajová, Bernardo Stefanini, & Francesco Tovoli. (2021). Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development. Expert Opinion on Investigational Drugs. 30(7). 759–772. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yehia I. Mohamed Breakdown of academic impact, for papers by Yasutoshi Fujii Breakdown of academic impact, for papers by Voytek Slowik Breakdown of academic impact, for papers by Haifu Wu Breakdown of academic impact, for papers by M.L. González-Diéguez Breakdown of academic impact, for papers by Jiong-Jie Yu Breakdown of academic impact, for papers by J. Zou Breakdown of academic impact, for papers by Peter R. Galle Breakdown of academic impact, for papers by Marta Piqué‐Gili Breakdown of academic impact, for papers by Mario Domenico Rizzato
Rankless by CCL
2026